HONG KONG DRUG LICENSING

Hong Kong Drug Licence FAQs

Search 500 Hong Kong drug licence FAQs on applications, personnel, premises, quality systems, ongoing regulation, renewals and acquisitions.

Information status: The original FAQ material dates from 2025 and is provided for topic-based reference; it does not represent an individual verification of all 500 FAQs against current rules. For application, fee, renewal, change, product or prescription requirements, please refer to the current official forms and guidance.

Official information from the Drug Office Official information from the Chinese Medicines Board

找到 500 条结果，第 13／25 页。每页显示 20 条；无需启用 JavaScript。

Thematic illustration for pharmaceutical licensing business queries and document organisation services — Discuss actual operating questions one-to-one to clarify the next decision.

Q241 · 在整个申请过程中，我作为公司董事，扮演什么角色？是否必须亲自参与所有环节？独立链接

As a director of the applicant company, you are ultimately responsible for the entire project and are legally accountable for the success of the application and the company's future compliant operations. Your core role is to make decisions and provide resources. You need to make key decisions, such as approving the budget, selecting the premises and appointing the RP. You must also ensure that sufficient resources are provided to support the establishment of a fully compliant operating system. During the application process, you do not necessarily need to handle every technical detail personally, such as completing forms or drafting SOPs; these tasks may be delegated to professional consultants such as us. However, your involvement is necessary at certain key stages, such as when developing the overall application strategy with us and when reviewing and signing the application documents. In addition, although uncommon, in certain special circumstances the PPB may wish to meet with company directors to understand their commitment to the business and awareness of the importance of compliance.

📘 Regulatory basis

The Companies Ordinance sets out directors’ duties, including the duty to exercise reasonable care, skill and diligence. In the context of medicines regulation, this means directors are responsible for ensuring that the company complies with all relevant laws and regulations, including the Pharmacy and Poisons Ordinance.

📗 Drew Tang's recommendations

We recommend that directors adopt a management approach of “active oversight and professional delegation”. Professional matters should be entrusted to professionals, while a clear reporting mechanism should be established to keep you regularly informed of application progress and any issues encountered. We will provide regular project reports, enabling you to retain full oversight without being burdened by day-to-day details.

📕 Risk notice

The greatest risk is “complete disengagement”. If directors take no interest in the application process and rely entirely on subordinates or consultants, key decisions may be delayed or made incorrectly. More seriously, directors cannot disclaim responsibility by saying they “did not know” if the company commits a serious breach in the course of its operations. The regulator and the courts may hold directors personally liable.

Q242 · 如果在申请期间，我的公司收到了关于某个计划经营产品的投诉，我该如何处理？独立链接

📘 Regulatory basis

The Code of Practice for Wholesale Dealers requires licence holders to have written procedures for handling product complaints. Although you are not yet a licence holder during the application period, establishing this procedure in advance is important evidence that you are capable of becoming a qualified licence holder.

📗 Drew Tang's recommendations

We will draft a world-class complaint-handling SOP for you. If such a situation arises, we will guide you on how to initiate the process, communicate with the supplier and document the entire handling process to create a complete “case file”. This file will be a powerful demonstration of your professionalism when communicating with inspectors.

📕 Risk notice

The risk lies in disregarding potential complaints. If you assume “I have not started operating yet, so it has nothing to do with me” and ignore a complaint, this sends a dangerous signal. If the product later develops a genuine quality issue and the regulator discovers that you had an opportunity to raise the alarm but took no action, your credibility will be seriously damaged.

Q243 · 申请药剂制品制造商（药厂）牌照的审批程序与批发商牌照有何天壤之别？独立链接

📘 Regulatory basis

The GMP guidelines published by the Pharmaceutical Inspection Co-operation Scheme (PIC/S) are globally recognised standards and are a principal basis on which the Hong Kong Department of Health approves pharmaceutical manufacturers. Hong Kong law also requires all medicines sold in Hong Kong to be manufactured by a licensed manufacturer.

📗 Drew Tang's recommendations

Setting up a pharmaceutical manufacturing plant is a major undertaking that requires top-level professional support. Rengangyongsheng (Hong Kong) Limited has a team of experienced GMP experts with backgrounds in international pharmaceutical manufacturing. We can provide end-to-end, turnkey consultancy services, from conceptual plant design, process layout, equipment selection and system establishment to final GMP certification. This decision requires careful planning and substantial investment, so we recommend discussing it with us in depth before getting started.

📕 Risk notice

The greatest risk is underestimating the complexity of GMP and the ongoing investment it requires. GMP certification is not a one-off exercise: you must continue to invest substantial resources in maintaining the GMP system and undergo recertification periodically. Any lapse, such as loss of control over the cleanroom environment or incomplete batch records, may result in suspension of your manufacturing licence and the loss of your entire investment.

Q244 · 我是否可以用一个虚拟办公室（Virtual Office）地址来注册公司和申请药品牌照？独立链接

📘 Regulatory basis

Both the Code of Practice for Wholesale Dealers and the Code of Practice for the Guidance of Pharmacy have extensive provisions on the specific physical requirements for “premises”. A virtual office clearly cannot meet any of them. The licence application form also expressly requires a physical business address.

📗 Drew Tang's recommendations

We recommend that clients clearly distinguish between the two concepts: the company’s registered address may be a company secretarial firm’s address or a virtual office selected for convenience; however, the licensed address for the medicines licence must be a fully compliant physical warehouse or shop into which you have invested heavily and made careful preparations. Ensure that these two addresses are not confused on any form.

📕 Risk notice

The risk lies in confusion about the meaning of “address”. Incorrectly declaring a virtual office address in a licence application could not only result in rejection, but also cause the regulator to question your professionalism and seriousness. This may have an unnecessary negative impact if you later reapply using a genuine address. This elementary mistake should be avoided altogether.

Q245 · 在现场视察时，除了负责人（RP），其他员工是否也可能被督察提问？独立链接

📘 Regulatory basis

The Code of Practice for Wholesale Dealers stresses the importance of ongoing training for all staff engaged in wholesale activities. Spot questions are a direct way to assess the effectiveness of training and an effective means of checking whether SOPs are “embedded in staff practice”.

📗 Drew Tang's recommendations

“Everyone is ready for action” is our training philosophy. Before an inspection, we not only provide focused guidance to your RP but also offer tailored question-and-answer training and practice sessions for all your key staff, such as warehouse supervisors and quality assistants. We ensure that when inspectors ask questions, every team member can give confident, accurate answers that fully accord with your SOPs.

📕 Risk notice

The risk is that “only the RP understands it”. If inspectors find that staff other than the RP know nothing about the SOPs, or that actual practices differ significantly from the SOPs, they may reach a very negative conclusion: that your quality system is merely a “paper exercise” created to get through inspections. This would be a major deficiency and could well result in a failed inspection.

Q246 · 如果我的负责人（RP）在申请过程中突然离职，我该怎么办？独立链接

📘 Regulatory basis

The person responsible is one of the core elements of a pharmaceutical licence application. Without a qualified person responsible, the applicant entity is no longer complete and the application process must be suspended. This reflects the regulator’s recognition of the critical role of people in a quality system.

📗 Drew Tang's recommendations

To deal with this unexpected situation, we recommend appointing and training one or two deputy RPs at the start of the project. If the RP leaves, you can immediately apply to the Department of Health to appoint the most experienced deputy RP as the formal RP. As this deputy RP’s details will already have been submitted with the application and they will already have received training, the Department of Health’s review is likely to be much faster, minimising delays caused by personnel changes.

📕 Risk notice

The greatest risk is “delay” and “concealment”. If you try to conceal the fact that the RP has left, or delay appointing a new RP, your application may ultimately be refused on the grounds that you “cannot meet the basic requirements”. This not only wastes all the time and resources invested so far, but also seriously damages your credibility with the regulator.

Q247 · 我的业务包含对药品进行二次包装（Secondary Packaging），这在审批上有什么额外要求？独立链接

📘 Regulatory basis

Under PIC/S GMP guidelines, secondary packaging is considered part of manufacturing. Accordingly, such activities require explicit authorisation from the Department of Health and must comply with simplified GMP requirements, also known as “GMP-light”.

📗 Drew Tang's recommendations

If you need to carry out secondary packaging, we will plan for this specifically from the start of the project. We will design a compliant packaging room, draft a complete set of packaging SOPs and guide you on preparing batch packaging records correctly. We will ensure that, when you apply, you can clearly demonstrate to the Department of Health that you are capable of carrying out safe, compliant secondary packaging.

📕 Risk notice

The risk lies in repackaging without authorisation. If you hold only an ordinary Wholesale Dealer Licence but secretly split packs or relabel products in your warehouse, this amounts to serious unlicensed manufacturing. If discovered, the consequences will be severe: your Wholesale Dealer Licence may be revoked, and the company and persons responsible may also face criminal prosecution.

Q248 · 在正式递交全套申请文件之前，我应该做哪些最终的检查？独立链接

📘 Regulatory basis

The Department of Health’s application guide clearly lists the documents that must be submitted. Any missing or incorrect document may be sufficient reason for an reviewing officer to request further information, triggering the first stage of a delay.

📗 Drew Tang's recommendations

As your consultant, we will carry out this final quality-control step for you. After you have signed all the documents, we will conduct an independent final review, cross-checking everything. We will put ourselves in the position of the most meticulous reviewing officer and try to identify potential issues in every detail. The application will not be submitted until it has passed our internal approval. This is the final safeguard underpinning our commitment to a “zero-defect application”.

📕 Risk notice

The risk is that “everything falls at the final hurdle”. You may spend months carefully preparing the premises and SOPs, only for your application to be returned because of a simple clerical error, such as an incorrectly named payee on a cheque or a missing signature on a document. This is not only frustrating but also wastes valuable time. A thorough final check is key to avoiding such elementary mistakes.

Q249 · 我的申请获批后，牌照的有效期是多久？我需要提前多久准备续期？独立链接

📘 Regulatory basis

The Pharmacy and Poisons Regulations set out the validity period and renewal requirements for licences. Licence holders are responsible for proactively and promptly renewing their licences to maintain their lawful operating status.

📗 Drew Tang's recommendations

For our annual service clients, licence renewal is a basic part of our service. We will maintain a renewal calendar and remind you automatically at the right time, as well as prepare all renewal documents for you to sign. We will handle all submissions and follow-up work to ensure continuity of your licence, so you do not need to worry about it.

📕 Risk notice

The greatest risk is “forgetting to renew”. This may sound unbelievable, but it can happen amid busy business operations. Once your licence expires without renewal, you must immediately cease all licensed activities. Reactivating the licence may require a process more complicated than a normal renewal and may even require a new on-site inspection. This can seriously disrupt and damage your business.

Q250 · 在整个申请和审批程序中，仁港永胜（RGYS）具体能为我提供哪些核心价值？独立链接

📘 Regulatory basis

All our services are firmly grounded in a thorough understanding and precise application of the Pharmacy and Poisons Ordinance, the Chinese Medicine Ordinance, and all relevant codes of practice and international standards (such as GSDP and GMP).

📗 Drew Tang's recommendations

The consultancy team led by our founder, Mr Tang Shangyong (Drew Tang), is your assurance of success. We are not merely your consultants; we are your business partners. We firmly believe that your success is our greatest success. We are committed to supporting you at every step of the application process with the highest professional standards and a customer-first service ethos.

📕 Risk notice

Choosing an unprofessional or inexperienced consultant is one of the greatest investment risks. Poor advice or an inadequate document may delay your application by months or even lead to refusal, wasting all your investment and effort. In the specialist field of compliance, choosing the right partner is the first and most important business decision you will make.

Q251 · 申请香港药剂制品批发商牌照，需要支付哪些主要的政府费用？独立链接

To apply for a pharmaceutical product wholesale dealer licence in Hong Kong, you must pay two basic government fees to the Drug Office, Department of Health. First, the “application fee” is HKD 1,030 under the current requirements. This fee is paid when you submit your application documents and covers the administrative costs of assessing your eligibility and documents. Second, after your application receives in-principle approval, you must pay a “licence fee” of HKD 2,150 before the Department of Health formally issues the licence. These two fees are statutory basic costs and form the initial financial threshold for obtaining a licence.

📘 Regulatory basis

The relevant fees are expressly set out in Schedule 3 to the Pharmacy and Poisons Regulations (Cap. 138A of the Laws of Hong Kong). The Schedule details the statutory fees for various applications, registrations and renewals relating to pharmacy and poisons.

📗 Drew Tang's recommendations

Please regard the application fee of HK$1,030 and the licence fee of HK$2,150 as just the “tip of the iceberg” of start-up costs. Our experience at Rengangyongsheng (Hong Kong) Limited shows that the actual financial investment required is far greater. You must set aside sufficient funds in your budget for professional consultancy services, compliant warehouse rental, establishment of a Quality Management System (QMS) and legal advice.

📕 Risk notice

Please note that the application fee paid is non-refundable, whether or not your application is successful. Therefore, before submitting an application, we strongly recommend seeking professional assistance to ensure that all documents and preparations meet the Department of Health’s stringent standards and avoid unnecessary financial loss due to omissions.

Q252 · 开设一家持牌药房（获授权毒药销售商），除了牌照申请费，还需要考虑哪些初期一次性投入？独立链接

The initial one-off costs of opening a licensed pharmacy are far greater than the licence application fee alone. You should focus on budgeting for the following: first, premises renovation and equipment. The shop must be laid out in strict accordance with the Department of Health’s requirements, including a separate dispensing area, a dangerous goods storage cabinet, and air-conditioning and refrigeration equipment that meet temperature and humidity control requirements. Second, security systems. A 24-hour CCTV surveillance system and an alarm system connected to a security company must be installed. Third, the initial medicine procurement, which requires a substantial amount of working capital. Finally, you should also budget for computer software for inventory management and sales records, and the consultancy service fee for engaging specialists such as us.

📘 Regulatory basis

The Code of Practice for Authorised Sellers of Poisons issued by the Pharmacy and Poisons Board (PPB) of Hong Kong contains detailed and mandatory requirements for pharmacy premises layout, facilities, storage conditions and security measures. These are statutory standards that must be met at the outset.

📗 Drew Tang's recommendations

Based on our experience assisting clients, we recommend setting aside at least 6 to 12 months of operating funds as a reserve. The largest initial capital expenses are often premises renovation and the first stock of medicines. When selecting premises, carefully assess their renovation potential and costs to avoid choosing a unit that is difficult to bring into compliance.

📕 Risk notice

Seriously underestimating initial investment is one of the most common reasons for the failure of a new pharmacy. If cash flow runs short soon after opening, you may be unable to maintain normal operations even if you have successfully obtained a licence. The regulator may ultimately suspend or revoke the licence, and all your initial investment may be lost.

Q253 · 聘请一名全职注册药剂师作为“获授权人”，大概的薪酬范围是多少？这将如何影响我的总体预算？独立链接

Hiring a qualified full-time registered pharmacist is one of the main costs of opening a licensed pharmacy and has a decisive impact on your financial budget. Based on market rates, a newly registered pharmacist with limited experience in Hong Kong generally earns between HKD 40,000 and HKD 50,000 per month. If you need a more experienced senior pharmacist to manage the pharmacy, the monthly salary may be as high as HKD 60,000 to HKD 80,000 or more. This is a fixed monthly staffing cost and must be treated as a top-priority operating expense in your financial model.

📘 Regulatory basis

Under the Pharmacy and Poisons Ordinance (Cap. 138), a licensed pharmacy (an Authorised Seller of Poisons (ASP)) must have a registered pharmacist present at all times during its business hours to personally supervise the sale of all pharmaceutical products. This is a non-negotiable legal requirement.

📗 Drew Tang's recommendations

The pharmacist is the professional core of your pharmacy and the person legally responsible for it. Their remuneration is a key investment in ensuring service quality and compliant operations. To attract and retain excellent staff, when drawing up a remuneration package we recommend considering benefits in addition to basic salary, such as a year-end double salary, performance bonuses, medical insurance and professional training allowances, to make the position more attractive.

📕 Risk notice

Recruitment difficulty and the time required must be fully considered in the business plan. If your pharmacist leaves and a replacement cannot be found in time, your Pharmacy may be unable to operate lawfully, and every day of closure means direct financial losses and loss of customers. It is therefore essential to maintain a good staffing pipeline or working relationships.

Q254 · 我计划申请中药材零售商牌照，其政府收费与西药牌照有何不同？独立链接

Government fees for an application to retail Chinese herbal medicines differ from those for Western medicine licences. Applications are handled by the Chinese Medicines Board under the Chinese Medicine Council of Hong Kong (CMCHK). Specifically, the application fee for a Chinese herbal medicine retailer licence is HK$770, and the issue fee upon successful approval is HK$1,160. By comparison, the application and issue fees for a Wholesale Dealer Licence are HK$1,030 and HK$2,150 respectively. Although government fees alone make Chinese medicine licences appear slightly less expensive, this does not mean the overall start-up costs are lower; other investments remain the main expenses.

📘 Regulatory basis

The relevant fees are prescribed in the subsidiary legislation, the Chinese Medicines Regulations, under the Chinese Medicine Ordinance (Cap. 549 of the Laws of Hong Kong). The Regulations list the statutory fees for applications, renewals and other matters relating to the different Chinese medicine business licences, including retail, wholesale and manufacture.

📗 Drew Tang's recommendations

Although government fees vary, when preparing your budget you should focus on common major expenses such as shop rent, storage facilities that comply with the Hong Kong Chinese Materia Medica Standards, including protection against damp and insect infestation, staff training and the cost of engaging Chinese medicine professionals. These are the key factors determining your total investment.

📕 Risk notice

Do not underestimate the complexity and funding requirements of starting a Chinese herbal medicine retail business because government licence fees are low. Quality control, traceability management and storage conditions for Chinese herbal medicines are subject to stringent requirements. Insufficient investment in these areas may not only result in the licence application being rejected, but could also lead to severe legal penalties for selling substandard herbal medicines.

Q255 · 牌照续期是否需要付费？西药和中药牌照的续期费用分别是多少？独立链接

Yes, all pharmaceutical and Chinese medicine licences are non-permanent and must be renewed periodically, with the applicable fees paid. For western medicine licences, such as a pharmaceutical product wholesaler licence, the annual renewal fee is 2,150 units, the same as the initial issue fee. An annual fee must also be paid each year for an Authorised Seller of Poisons (ASP) (pharmacy) licence. For Chinese medicine licences, such as a retail licence for Chinese herbal medicines, the annual renewal fee is 1,160 units. These renewal fees are necessary ongoing expenses for maintaining your lawful right to operate and must be paid on time.

📘 Regulatory basis

Renewal fees for Western medicine licences are specified in the Third Schedule to the Pharmacy and Poisons Regulations (Cap. 138A). Renewal fees for Chinese medicine licences are specified in the Chinese Medicine Regulation (subsidiary legislation under Cap. 549). The regulatory authorities review these fees periodically and may adjust them.

📗 Drew Tang's recommendations

We strongly recommend setting up a “compliance calendar” that clearly marks important dates, such as licence renewal dates and payment deadlines. The Drug Office or Chinese Medicines Board usually sends renewal notices in advance, but as the licence holder, you remain ultimately responsible for ensuring timely renewal. Include this annual expense as a fixed item in your annual financial budget.

📕 Risk notice

Failure to pay the renewal fee on time will cause the licence to expire automatically. Once the licence has expired, you must immediately stop all related pharmaceutical business activities; otherwise, your operations will be illegal. Reapplying for a licence is time-consuming and demanding, and may involve more stringent scrutiny. Any delay could therefore have a disastrous impact on your business.

Q256 · 在香港租赁符合药物办公室检查标准的仓储或店铺，租金成本大概占总预算的多少？独立链接

Premises rent is one of the main costs of starting a pharmaceutical business. Its share of the total budget varies depending on location, floor area and licence type, but is generally substantial. Monthly rent for a licensed pharmacy in an urban area with a floor area of about 500 to 1,000 square feet can easily reach tens of thousands to over a hundred thousand Hong Kong dollars. For a wholesaler’s warehouse requiring more space and specific logistics conditions, rent is also a major expense, even in an industrial area. In the initial budget, we generally recommend allocating at least 30% to 40% of funds to cover the initial rent, deposit (typically two months’ deposit plus one month’s rent in advance) and a rent reserve for at least six months after opening.

📘 Regulatory basis

The Drug Office, Department of Health’s Guide to the Licensing of Wholesale Dealers of Pharmaceutical Products and Code of Practice for Authorised Sellers of Poisons both set out clear requirements for premises area, layout, security and environmental control (temperature and humidity). These requirements directly affect the range of properties you can choose from and their rental levels.

📗 Drew Tang's recommendations

Site selection is a key step in determining success or failure. Before signing a tenancy agreement, Rengangyongsheng recommends that clients ask us or their appointed consultant to conduct a preliminary assessment of the property and determine whether it can be adapted cost-effectively. A property that appears to have low rent but requires substantial refurbishment may have higher ‘hidden costs’.

📕 Risk notice

The greatest risk is discovering only after signing a long-term lease that the premises cannot pass the Department of Health's on-site inspection because of structural, fire safety or ventilation issues. This may leave you locked into the lease without being able to obtain a licence, creating a financial dilemma. Make passing the Department of Health inspection one of the key conditions precedent to the lease.

Q257 · 除了药剂师，我还需要聘请哪些员工？他们的人力成本如何规划？独立链接

In addition to the registered pharmacist required by law, a smoothly operating pharmacy or pharmaceutical wholesaler also needs other key staff. A pharmacy will need at least 1–2 dispensers or trainee dispensers to assist the pharmacist with handling prescriptions, managing inventory and selling non-prescription medicines. Cashiers and shop cleaning staff are also needed. A wholesaler will need warehouse staff, clerical staff responsible for order processing and logistics, and sales representatives. When preparing your budget, calculate for each employee their basic salary, Mandatory Provident Fund (MPF) contributions, employees’ compensation insurance, and potential year-end bonuses and overtime pay in accordance with Hong Kong’s employment legislation.

📘 Regulatory basis

The Employment Ordinance (Cap. 57) and the Mandatory Provident Fund Schemes Ordinance (Cap. 485) are fundamental laws that you must comply with when planning staffing costs. In addition, the Pharmacy and Poisons Board's (PPB) codes of practice require sufficient personnel with appropriate training to support pharmacy operations.

📗 Drew Tang's recommendations

We recommend considering part-time staff or more flexible shift arrangements during the initial period of operation to control labour costs. Ongoing professional training for staff is not only a compliance requirement but also a key investment in service quality and operational efficiency. A well-trained dispenser can greatly ease the pharmacist’s workload.

📕 Risk notice

An insufficient labour cost budget may reduce service quality and increase compliance risks. For example, staff shortages may leave a pharmacist unable to supervise all medicine sales effectively. Any error could result in severe disciplinary action. Breaches of the Employment Ordinance may also lead to prosecution and fines by the Labour Department.

Q258 · 申请药品生产牌照（制造商牌照）的财务门槛有多高？主要投资在哪里？独立链接

Applying for a pharmaceutical product manufacturer's licence (Pharmaceutical Manufacturer License) has the highest financial threshold of all licence types, and the investment is typically measured in tens of millions of Hong Kong dollars. The main investment areas are as follows. First, “factory construction and certification”: you need to establish a facility meeting Good Manufacturing Practice (GMP) standards, including specially designed cleanrooms, separate stores for materials and finished products, and advanced ventilation and water treatment systems. Second, “production and testing equipment”: substantial investment is required to purchase GMP-compliant production line equipment and precision analytical instruments for the quality control laboratory. Finally, “specialist technical staff”: highly skilled personnel, including a production supervisor and quality control/quality assurance managers, must be employed.

📘 Regulatory basis

The Pharmacy and Poisons Board (PPB) requires all licensed pharmaceutical product manufacturers to comply with the PIC/S Guide to Good Manufacturing Practice for Medicinal Products. This is the core technical and legal standard for applying for and maintaining a licence.

📗 Drew Tang's recommendations

For investors interested in entering pharmaceutical manufacturing, Rengangyongsheng (Hong Kong) Limited generally recommends conducting a highly detailed feasibility study and financial planning. Consider starting with contract manufacturing (CMO), using the capacity of an existing licensed manufacturer, and only considering a facility of your own once the market and products have matured. This can substantially reduce initial investment risk.

📕 Risk notice

Constructing and certifying a GMP facility takes a long time, requires substantial investment and involves considerable uncertainty. Failure at any stage of the stringent PIC/S review may cause the entire project to fail, resulting in substantial financial losses. This is a highly specialised, capital- and technology-intensive field and should not be entered into lightly.

Q259 · 聘请像仁港永胜这样的专业顾问公司，服务费用是如何构成的？这笔投资是否值得？独立链接

The fees charged by a professional consultancy such as Rengangyongsheng are generally based on the complexity of the project, the types of licences required and the scope of services. The fee structure generally includes: 1. ‘Initial consultation and assessment fee’: a feasibility analysis of your business plan and existing resources. 2. ‘Full application representation fee’: acting as your authorised representative and managing the entire process, from document preparation and form completion to communication with government departments, accompanying you during on-site inspections and the eventual issue of the licence. This is usually the largest component of the fees. 3. ‘Additional service fees’: for example, assistance with recruiting key personnel, establishing a Quality Management System (QMS) or providing annual compliance maintenance services. This investment is definitely worthwhile: it can save you a great deal of time, help you avoid missteps and maximise your chances of a successful application.

📘 Regulatory basis

Although the law does not require you to engage a consultant, the application guidance issued by the Department of Health and the Chinese Medicines Board is extensive, complex and subject to strict approval standards. A professional consultant’s role is to ensure that your application fully meets these statutory requirements.

📗 Drew Tang's recommendations

“Leave professional work to professionals.” We turn a complex application process into clear action steps and use our experience to help you avoid common mistakes. The consultancy service fee should be viewed as a form of “insurance” and an “accelerator”; its value far exceeds the fee itself. It turns what would otherwise be an uncertain application process into a predictable, manageable project.

📕 Risk notice

Choosing an unprofessional consultant or attempting to handle the entire application yourself (DIY) is one of the greatest risks. We have seen too many applications delayed or even refused because of errors in document details, inadequate understanding of the regulations or insufficient preparation for on-site inspections. This attempt to ‘save money’ often ends up causing greater opportunity costs and actual losses.

Q260 · 在制定药品业务的财务预算时，有哪些容易被忽略的“隐性成本”？独立链接

When preparing a financial budget, in addition to visible costs such as rent, salaries and payments for goods, many “hidden costs” should not be overlooked. These include: 1. “Annual mandatory continuing professional development (CPD) costs”: pharmacists and certain Chinese medicine practitioners need to complete a specified number of hours of further training. 2. “Software system maintenance and upgrade costs”: your inventory and sales management systems require regular maintenance and functional upgrades to meet regulatory requirements. 3. “Pharmaceutical waste disposal costs”: expired or non-conforming pharmaceutical products must be destroyed by a licensed specialist company, creating an ongoing expense. 4. “Various insurance premiums”, including public liability, property and employees’ compensation insurance. 5. “Bank charges and transaction costs”: transfers of funds in day-to-day operations incur fees.

📘 Regulatory basis

The Code of Practice for Authorised Sellers of Poisons and the Guidance Notes on Wholesale Dealer Licensing both imply requirements for personnel training, record-keeping and waste disposal. These translate directly into operating costs. For example, proper disposal of discarded medicines is an important part of preventing medicine misuse.

📗 Drew Tang's recommendations

We recommend including a “miscellaneous and contingency” category in your financial budget, typically amounting to 5% to 10% of total operating costs, to cover these unforeseen “hidden costs”. A well-considered budget should have some flexibility to cope with various unexpected circumstances.

📕 Risk notice

Ignoring these hidden costs can make your cash flow projections overly optimistic. As these ‘small’ but recurring expenses accumulate, they can significantly erode your profits and even trigger a liquidity crisis during a difficult period. Make sure these costs are adequately estimated in your financial model.

Hong Kong Drug Licence FAQs

Plan Your Hong Kong Pharmaceutical Licensing Project with Drew Tang